21 Results for "

Kit-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (21)

21 Results for "Kit-IN-1" in MCE Product Catalog:

Cat. No.: HY-187462
CAS No.: 3080682-21-6
Target:  

c-Kit

Research Areas:  

Inflammation/Immunology

Kit-IN-1 is a kinome-selective and orally active KIT inhibitor with a human IC50 value of 2.8 nM. Kit-IN-1 binds to KIT in an allosteric mode, stabilizes the inactive DFG-out conformation of KIT, and blocks the stem cell factor (SCF)-mediated KIT phosphorylation signaling pathway. Kit-IN-1 inhibits SCF-induced ear swelling in rats and prevents increased vascular permeability. Kit-IN-1 can be used in studies related to mast cell-driven chronic inflammation [1].
loading...
    loading...
25
25 Publications Verification
Cat. No.: HY-10208
CAS No.: 444731-52-6
Purity:  99.91%
Synonyms: GW786034
Research Areas:  

Cancer

Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with IC50s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.
loading...
    loading...
25
25 Publications Verification
Cat. No.: HY-12009
CAS No.: 635702-64-6
Purity:  99.99%
Synonyms: GW786034 Hydrochloride
Research Areas:  

Cancer

Pazopanib Hydrochloride (GW786034 Hydrochloride) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with an IC50 of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-50905
CAS No.: 405169-16-6
Synonyms: CHIR-258; TKI258
Target:  

FLT3 c-Kit FGFR VEGFR PDGFR c-Fms

Research Areas:  

Cancer

Dovitinib (CHIR-258) is an orally active, potent multi-targeted tyrosine kinase (RTK) inhibitor with IC50s of 1, 2, 36, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, CSF-1R, FGFR1/FGFR3, VEGFR1/VEGFR2/VEGFR3 and PDGFRα/PDGFRβ, respectively. Dovitinib has potent antitumor activity [1] .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-138813
Purity:  99.14%
Synonyms: SU-12662 hydrochloride
Target:  

Drug Metabolite

Research Areas:  

Cancer

N-Desethyl Sunitinib (SU-12662) (hydrochloride) is a metabolite of sunitinib. Sunitinib is a potent, ATP-competitive VEGFR, PDGFRβ and KIT inhibitor with Ki values of 2, 9, 17, 8 and 4 nM for VEGFR -1, -2, -3, PDGFRβ and KIT, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-15240
CAS No.: 1225278-16-9
Purity:  98.83%
Target:  

c-Kit c-Met/HGFR

Research Areas:  

Cancer

c-Kit-IN-1 is a potent inhibitor of c-Kit and c-Met with IC50s of <200 nM.
loading...
    loading...
Cat. No.: HY-P99462
CAS No.: 2438203-51-9
Synonyms: CDX-0159

Target:  

c-Kit

Research Areas:  

Inflammation/Immunology

Barzolvolimab is a humanized anti-KIT IgG1 monoclonal antibody. Barzolvolimab specificity and potently inhibits KIT activation by SCF. Barzolvolimab can reduce skin mast cells and disease activity in chronic inducible urticaria [1].
loading...
    loading...
Cat. No.: HY-170517
CAS No.: 3065631-84-4
Target:  

Wee1 Ephrin Receptor

Research Areas:  

Cancer

PKMYT1-IN-8 (Compound 137) is the inhibitor for PKMYT1 with an IC50 of 9 nM. PKMYT1-IN-8 inhibits EPHB3, EPHA1, KIT, EPHB1, EPHA2, EPHA3, and EPHB2with IC50s of 1.79, 3.17, 4.29, 6.32, 6.83, 8.10, and 10.9 μM, respectively. PKMYT1-IN-8 inhibits the proliferation of cancer cell OVCAR3 with GI50 of 2.02 μM [1].
loading...
    loading...
Cat. No.: HY-10208S
CAS No.: 1219592-01-4
Purity:  ≥98.0%
Synonyms: GW786034-d6
Pazopanib-d6 is the deuterium labeled Pazopanib. Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with IC50s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.
loading...
    loading...
Cat. No.: HY-10873S
CAS No.: 1217247-62-5
N-Desethyl Sunitinib-d5 is the deuterium labeled N-Desethyl Sunitinib. N-Desethyl Sunitinib (SU-12662) is a metabolite of sunitinib. Sunitinib is a potent, ATP-competitive VEGFR, PDGFRβ and KIT inhibitor with Ki values of 2, 9, 17, 8 and 4 nM for VEGFR -1, -2, -3, PDGFRβ and KIT, respectively .
loading...
    loading...
Cat. No.: HY-50905R
CAS No.: 405169-16-6
Synonyms: CHIR-258 (Standard); TKI258 (Standard)
Research Areas:  

Cancer

Dovitinib (Standard) is the analytical standard of Dovitinib. This product is intended for research and analytical applications. Dovitinib (CHIR-258) is an orally active, potent multi-targeted tyrosine kinase (RTK) inhibitor with IC50s of 1, 2, 36, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, CSF-1R, FGFR1/FGFR3, VEGFR1/VEGFR2/VEGFR3 and PDGFRα/PDGFRβ, respectively. Dovitinib has potent antitumor activity [1] .
loading...
    loading...
Cat. No.: HY-12009R
CAS No.: 635702-64-6
Synonyms: GW786034 Hydrochloride (Standard)
Research Areas:  

Cancer

Pazopanib (Hydrochloride) (Standard) is the analytical standard of Pazopanib (Hydrochloride). This product is intended for research and analytical applications. Pazopanib Hydrochloride (GW786034 Hydrochloride) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with an IC50 of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.
loading...
    loading...
Cat. No.: HY-10208R
CAS No.: 444731-52-6
Synonyms: GW786034 (Standard)
Research Areas:  

Cancer

Pazopanib (Standard) is the analytical standard of Pazopanib. This product is intended for research and analytical applications. Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with IC50s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.
loading...
    loading...
Cat. No.: HY-W705479
CAS No.: 2469755-67-5
Synonyms: GW786034-d3 hydrochloride
Pazopanib-d3 (hydrochloride) (GW786034-d3 (hydrochloride)) is deuterium labeled Pazopanib (Hydrochloride). Pazopanib Hydrochloride (GW786034 Hydrochloride) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with an IC50 of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.
loading...
    loading...
Cat. No.: HY-10208S2
CAS No.: 1219591-97-5
Synonyms: GW786034-d3
Pazopanib-d3 (GW786034-d3) is deuterium labeled Pazopanib. Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with IC50s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively [1].
loading...
    loading...
Cat. No.: HY-50905S
CAS No.: 1246819-84-0
Dovitinib-d8 is the deuterium labeled Dovitinib. Dovitinib (CHIR-258) is a multi-targeted tyrosine kinase inhibitor with IC50s of 1, 2, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, FGFR1/FGFR3, VEGFR1/VEGFR2/VEGFR3 and PDGFRα/PDGFRβ, respectively [1] .
loading...
    loading...
Cat. No.: HY-W011873R
CAS No.: 373-49-9
Pazopanib (Hydrochloride) (Standard) is the analytical standard of Pazopanib (Hydrochloride). This product is intended for research and analytical applications. Pazopanib Hydrochloride (GW786034 Hydrochloride) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with an IC50 of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.
loading...
    loading...
Cat. No.: HY-12009S
CAS No.: 1261398-44-0
Purity:  97.51%
Synonyms: GW786034-13C,d3 hydrochloride
Pazopanib- 13C,d3 (hydrochloride) is the deuterium and 13C labeled Pazopanib hydrochloride [1]. Pazopanib Hydrochloride (GW786034 Hydrochloride) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with an IC50 of 10, 30, 47, 84, 74, 140 and 146 nM, respectively .
loading...
    loading...
Cat. No.: HY-10208S1
CAS No.: 1261734-88-6
Synonyms: GW786034-13C,d3
Pazopanib- 13C,d3 is the deuterium and 13C labeled Pazopanib [1]. Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with IC50s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively .
loading...
    loading...
Cat. No.: HY-10873R
CAS No.: 356068-97-8
Synonyms: SU-12662 (Standard)
Research Areas:  

Cancer

N-Desethyl Sunitinib (Standard) is the analytical standard of N-Desethyl Sunitinib. This product is intended for research and analytical applications. N-Desethyl Sunitinib (SU-12662) is a metabolite of sunitinib. Sunitinib is a potent, ATP-competitive VEGFR, PDGFRβ and KIT inhibitor with Ki values of 2, 9, 17, 8 and 4 nM for VEGFR -1, -2, -3, PDGFRβ and KIT, respectively[1].
loading...
    loading...